A lawsuit has been filed against Stanford Medicine, claiming that Alice Brock, a 75-year-old patient, was erroneously injected with an iodine contrast dye, Omnipaque 350, during a routine imaging test. The incident allegedly resulted in significant health deterioration, including loss of mobility and neurological functioning. Brock had a baclofen pump implanted to manage muscle spasms but experienced severe effects from the injection, including decreased sensation and increased weakness. The lawsuit accuses the medical providers of negligence and claims that Brock was not informed about the injection or did not give proper consent. Brock is seeking unspecified damages for pain, suffering, and loss of enjoyment of life. Named in the suit are Stanford Medicine, its Neuroscience Health Center, a neurosurgeon, and a radiologic technologist. The case is significant due to prior warnings from the FDA regarding the risks associated with intrathecal administration of the drug. Brock, now facing mobility challenges, has had to relocate from her multi-story home and is advocating to prevent similar incidents for future patients.
Mon, 13 Jul 2026 07:25:34 GMT | Radiology Business